Description Update of the 2009 started Continuous Assessment of molecular diagnostics from the end user perspective. Hospital and private laboratories have systematically been surveyed to collect information on number of labs testing, NA tests, test volumes, used platforms (separated for amplification, hybridization, detection) and reagents.
For data reliability and accurate projections at segment level a 3 step methodology has been applied: Step 1: Identification of the total number of labs Step 2: Identification of the total number of laboratories using NA technologies (in several lab units per hospital) Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 39 NA tests has been provided to the labs for structured data entry.
The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), Traditional and Next Generation Sequencing, TMA, LCR, NASBA, SDA, HCA, bDNA.
Executive Summary dii is an international market research company entirely specialised in healthcare markets providing market information and support to strategic business decisions. In cooperation with key industry we have desigend the Continuous Molecular Market Assessment which has been realized in 2009, 2012, 2014 and 2016 with the 2 main objectives: 1) Assess market size and shares for molecular diagnostics (# of labs using which technology, test volumes, platforms and reagents) 2) Understand long term trends and needs
Format of deliverables Excel - detailed data reports with extrapolation of # of labs, test volumes, market shares for platforms and reagents per country & test
Our reports have been used by over 10K customers, including:
Veterinary Molecular Diagnostic Market Research Report by Product (Instruments & Software, Kits & Reagent, and Services), by Technology (DNA Sequencing, Microarrays, and Polymerase Chain Reaction), by Animal Type, by Disease Indication, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global dPCR and qPCR Market Report The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the oncology molecular diagnostics market are Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare. The global oncology molecular diagnostics market is expected to decline from $5.58 billion...
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...
Molecular Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Molecular Diagnostics market including the COVID-19 pandemic implications...
The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices. By...
The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global mycoplasma testing industry’s growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical...
The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.